BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

iMDsoft Announces that United States Patent Office Re-Examination Successfully Limits Visicu Patent


2/27/2007 12:08:14 PM

BOSTON, Feb. 27 /PRNewswire/ -- The second re-examination requested by iMDsoft of a healthcare services patent owned by Visicu, Inc. has resulted in Visicu limiting all its patent claims.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070226/CLM182LOGO )

On February 6, 2007, the United States Patent and Trademark Office (USPTO) held all claims in Visicu's patent No. 6,804,656 to be invalid as not patentable.

The invalidity finding was based on prior art that includes iMDsoft's own patent disclosure, which pre-dates Visicu's patent.

All of the claims in Visicu's patent are affected.

The invalidity rejection by the USPTO forced Visicu on February 15, 2007 to narrow all the patent claims to require that the monitoring and intervention "occurs in an automated fashion at the remote command center" 24 hours per day 7 days per week. There is no "user intervention" or "user input."

Visicu explained that "The patient's care is at all times managed from the remote command center." Visicu advised the USPTO that its patent does not cover "intervention with the patient [that] does not occur in an automated fashion at the central station" or "is manually determined by the emergency service provider or a facility to which the patient is transported by the emergency service provider."

"We were pleased to learn about this important action of the USPTO," says Phyllis Gotlib, iMDsoft's CEO. "It clearly strengthens our competitive position in the market. We always believed that involving medical personnel produces safer medical care. In fact, the new Visicu claims have limited relevance to commercial systems, as virtually all medical care systems utilize medical personnel at some point during the 24/7 monitoring and intervention operations."

About iMDsoft

Founded in 1996, iMDsoft is leading the critical care Clinical Information and Anesthesia Information Management Systems marketplace, supporting the complete continuum of care in intensive care and perioperative environments including "telemonitoring" programs. iMDsoft 's MetaVision Suite, first commercially implemented in 1999, is a family of products designed to capture, integrate and analyze critical care information enabling improvements in patient care and more effective use of resources. The company - headquartered in Massachusetts and with offices in Europe, Israel, and Japan - is globally recognized for its innovative products and world-class service and support. MetaVision systems are successfully implemented in leading healthcare institutions across three continents.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070226/CLM182LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comiMDsoft

CONTACT: Press, Steve Sperrazza, Director of Sales of iMDsoft, Inc.,+1-781-449-5567, or Steve.Sperrazza@imd-soft.com



Read at BioSpace.com

iMDsoft
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES